Cytokine Activation of Endothelial Cells: New Molecules for an Old Paradigm

Alberto Mantovani; Silvano Sozzani; Annunciata Vecchi; Martino Introna; Paola Allavena

doi:10.1055/s-0038-1657561

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1997; 78(01): 406-414
DOI: 10.1055/s-0038-1657561

Cytokines and thrombosis

Schattauer GmbH Stuttgart

Cytokine Activation of Endothelial Cells: New Molecules for an Old Paradigm

Alberto Mantovani

¹Department of Immunology and cell Biology, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan

²Section of Pathology and Immunolgy, Department of Biotechnology, University of Brescia, Brescia, Italy

,

Silvano Sozzani

¹Department of Immunology and cell Biology, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan

,

Annunciata Vecchi

¹Department of Immunology and cell Biology, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan

,

Martino Introna

¹Department of Immunology and cell Biology, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan

,

Paola Allavena

¹Department of Immunology and cell Biology, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan

› Author Affiliations

Abstract

PDF Download

PDF (328 kb)

References

References
1 Mantovani A, Bussolino F, and Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bed side. Immunol Today. 1997. in press
2 Mantovani A, and Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989; 10: 370-375
3 Mantovani A, Bussolino F, and Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 06: 2591-2599
4 Bussolino F, and Camussi G. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur J Biochem 1995; 229: 327-337
5 Montrucchio G, Lupia E, Battaglia E, Passerini G, Bussolino F, Emanuelli G, and Camussi G. Tumor necrosis factor alpha- induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 1994; 180: 377-382
6 De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA J, Shin Ws, and Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68
7 Peng HB, Rajavashisth TB, Libby P, and Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 1995; 270: 17050-17055
8 Zeiher AM, Fisslthaler B, Schray UtzB, and Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 1995; 76: 980-986
9 Peng HB, Libby P, and Liao JK. Induction and stabilization of I kappa B alpha by niric oxide mediates inhibition of NFkappa B. J Biol Chem 1995; 270: 14214-14219
10 Kilgore KS, Shen JP, Miller BF, Ward PA, and Warren JS. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 1995; 155: 1434-1441
11 Saadi S, Holzknecht RA, Patte C, Stern DM, and Platt JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995; 182: 1807-1814
12 Breviario F, d’Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, Saccone S, Marzella R, Predazzi V, Rocchi M, Della Valle G, Dejana E, Mantovani A, and Introna M. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 1992; 267: 22190-22197
13 Introna M, Vidal Alles V, Castellano M, Picardi G, De Gioia L, Bottazzi B, Peri G, Breviario F, Salmona M, De Gregorio L, Dragani TA, Srinivasan N, Blundell TL, Hamilton TA, and Mantovani A. Cloning of mouse PTX3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 1996; 87: 1862-1872
14 Pober J, and Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-451
15 Maier JA, Statuto M, and Ragnotti G. Endogenous interleukin alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol 1994; 14: 1845-1851
16 Bradley JR, Thiru S, and Pober JS. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995; 146: 27-32
17 Mackay F, Loetscher H, Stueber D, Gehr G, and Lesslauer W. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 1993; 177: 1277-1286
18 Paleolog EM M, Delasalle SA, Buurman WA, and Feldmann A. Functional activities of receptors for tumor necrosis factor- alpha on human vascular endothelial cells. Blood 1994; 84: 2578-2590
19 Grell M, Douni E, Wajant H, Löheden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, and Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802
20 Schmid EF, Binder K, Grell M, Scheurich P, and Pfizenmaier K. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha. Blood 1995; 86: 1836-1841
21 Lukacs NW, Strieter RM, Elner V, Evanoff HL, Burdick MD, and KunkeL SL. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte endothelial cell interactions. Blood 1995; 86: 2767-2773
22 Colotta F, Dower SK, Sims JE, and Mantovani A. The type II ‘decoy’ receptor: novel regulatory pathway for interleukin-1. Immunol Today 1994; 15: 562-566
23 Grosset C, Jazwiec B, Taupin JL, Liu H, Richard S, Mahon FX, Reiffers J, Moreau JF, and Ripoche J. In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. Blood 1995; 86: 3763-3770
24 Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Gairone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Mahapatra BD, Rouvier E, Goldstein P, Banchereau J, and Lebecque S. T- cell IL-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183: 2593-2603
25 Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, and Stem D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 1995; 270: 11463-11471
26 Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, Van Damme J, Dejana E, and Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142: 549-553
27 Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, Van Hinsberg V, Sozzani S, Bussolino F, Poli V, Ciliberto G, and Mantovani A. IL-6, in concert with soluble IL-6 receptor, selectively induces chemokine production in endothelial cells and participates in the leukocyte recruitment in vivo. Immunity; 1997. in press
28 Bussolino F, Bocchietto E, Silvagno F, Soldi R, Arese M, and Mantovani A. Actions of molecules which regulate hemopeiesis on endothelial cells: memoirs of common ancestors?. Path Res Pract 1994; 190: 834-839
29 Korpelainen EI, Gamble JR, Smith WB, Dottore M, Vadas MA, and Lopez AF. Interferon-gamma upregulates interleukin-3 (IL-3) receptor expression in human endothelial cells and synergizes with IL-3 in stimulating major histocompatibility complex class II expression and cytokine production. Blood 1995; 86: 176-182
30 Sironi M, Munoz C, Pollicino T, Siboni A, Sciacca FL, Bemasconi S, Vecchi A, Colotta F, and Mantovani A. Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur J Immunol 1993; 23: 2692-2695
31 Chen CC, and Manning AW. TGF-betal, IL-10 and IL-4 differentially modulate the cytokine-induced expression of the IL-6 and IL-8 in human endothelial cells. Cytokine 1996; 8: 58-65
32 Debeaux AC, Maingay JP, Ross JA, Fearon KC H, and Carter DC. Interleukin-4 and interleukin-10 increase endotoxin- stimulated human umbilical vein endothelial cell interleukin-8 release. J Interferon Cytokine Res 1995; 15: 441-445
33 Vora M, Yssel H, de Vries JE, and Karasek MA. Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-gamma and IL-10. J Immunol 1994; 152: 5734-5741
34 Schoedon G, Schneemann M, Blau N, Edgell CJ, and Schaffner A. Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines: new perspectives on endothelium-derived relaxing factor. Biochem Biophys Res Commun 1993; 196: 1343-1348
35 Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, Hieke A, Multhoff G, Bomkamm GM, and Holler E. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endoxin. Blood 1995; 86: 4184-4193
36 Krakauer T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol Lett 1995; 45: 61-65
37 Wojta J, Gallicchio M, Zoellner H, Filonzi EL, Hamilton JA, and Mcgrath K. Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood 1993; 81: 3285-3292
38 Marfaingkoka A, Devergne O, Gorgone G, Portier A, Schall TJ, Galanaud P, and Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells - Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 1995; 154: 1870-1878
39 Sironi M, Sciacca FL, Matteucci C, Conni M, Vecchi A, Bemasconi S, Minty A, Caput D, Ferrara P, Colotta F, and Mantovani A. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994; 84: 1913-1921
40 Garcia de Frutos P, Hardig Y, and Dahlback B. Serum amyloid P component binding to C4b-binding protein. J Biol Chem 1995; 270: 26950-26955
41 Hollenbaugh D, Mischel Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, and Aruffo A. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182: 33-40
42 Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs A, Stem D, and Chess L. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 1995; 182: 1857-1864
43 Karmann K, Hughes CC, Schechner J, Fanslow WC, and Pober JS. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 1995; 92: 4342-4346
44 Voest EE, Kenyon BM, O’Reilly MS, Truitt G, D’Amato RJ, and Folkman J. Inhibition of angiogenesis in vivo by interleukin-12. J Natl Cancer Inst 1995; 87: 581-586
45 Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, and Dinarello CA. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 1994; 84: 4242-4248
46 Brown Z, Gerritsen ME, Carley WW, Strieter RM, Kunkel SL, and Westwick J. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells – Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon- gamma. Am J Pathol 1994; 145: 913-921
47 Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, and Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-1801
48 Schonbeck U, Brandt E, Petersen F, Flad HD, and Loppnow H. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995; 154: 2375-2383
49 Petzelbauer P, Watson CA, Pfau SE, and Pober JS. IL-8 and angiogenesis: Evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995; 7: 267-272
50 Luster AD, Greenberg SM, and Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995; 182: 219-231
51 Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, and Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995; 182: 155-162
52 Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MX, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan SY, Roczniak S, and Shanafelt AB. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995; 270: 27348-27357
53 Cao YU, Chen C, Weatherbee JA, Tsang M, and Folkman J. gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Exp Med 1995; 182: 2069-2077
54 Peiper SC, Wang ZJC, Neote K, Martin AW, Showell HJ, Conklyn MJ, Ogbome K, Hadley TJ, Lu ZH, Hesselgesser J, and Horuk R. The Duffy antigen receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181: 1311-1317
55 Rot A. Endothelial cell binding of NAP-l/IL-8: role in neutrophil emigration. Immunol Today 1992; 13: 291-294
56 Ley K, Baker JB, Cybulsky MI, Gimbrone MA, and Luscinskas FW. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol 1993; 151: 6347-6357
57 Colotta F, Orlando S, Fadlon EJ, Sozzani S, Matteucci C, and Mantovani A. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J Exp Med 1995; 181: 2181-2188
58 van Hinsbergh VW, Vermeer M, Koolwijk P, Grimbergen J, and Kooistra T. Genistein reduces tumor necrosis factor alpha- induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells. Blood 1994; 84: 2984-2991
59 Palmer-Crocker RL, and Pober JS. IL-4 induction of VC AM-1 on endothelial cells involves activation of a protein tyrosine kinase. J Immunol 1995; 154: 2838-2845
60 Schieven GL, Kallestad JC, Brown TJ, Ledbetter JA, and Linsley SP. Oncostatin M induces tyrosine phosphorylation in endothelial cells and activation of p62yes tyrosine kinase. J Immunol 1992; 149: 1676-1682
61 Weber C, Negrescu E, Erl W, Pietsch A, Frankenberger M, Ziegler Heitbrock HW, Siess W, and Weber PC. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol 1995; 155: 445-451
62 Modur V, Zimmerman GA, Prescott SM, and Mclntyre TM. Endothelial cell inflammatory responses to tumor necrosis factor alpha - Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J Biol Chem 1996; 271: 13094-13102
63 De Luca LG, Johnson DR, Whitley MZ, Tucker C, and Pober JS. cAMP and Tumor Necrosis Factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the Endothelial Leukocyte Adhesion Molecule-1 (E-selectin) promoter. J Biol Chem 1994; 269: 19193-19196
64 Whitley MZ, Thanos D, Read MA, Maniatis T, and Collins T. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol 1994; 14: 6464-6475
65 Kaszubska W, van Huijsduijnen RH, Ghersa P, DeRaemy Schenk AM, Chen BP, Hai T, DeLamarter JF, and Whelan J. Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol Cell Biol 1993; 13: 7180-7190
66 Pober JS, Slowik MR, De Luca LG, and Ritchie AJ. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993; 150: 5114-5123
67 Ghersa P, Hooft van Huijsduijnen R, Whelan J, Cambet Y, Pescini R, and DeLamarter JF. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem 1994; 269: 29129-29137
68 Masamune A, Igarashi Y, and Hakomori S. Regulatory role of ceramide in interleukin (IL)-l beta-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1 beta action, but is not sufficient for E-selectin expression. J Biol Chem 1996; 271: 9368-9375
69 Wiegmann K, Schütze S, Machleidt T, Witte D, and Krönke M. Functional dichotomy of neutral and acidic sphingomyelinases in Tumor Necrosis Factor signaling. Cell 1994; 78: 1005-1015
70 Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, and Krönke M. FAN, a novel WD-repeat protein couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 1996; 86: 937-947
71 Palmer-Crocker RL, Hugles CC W, and Pober JS. IL-4 andIL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gammaC chain. J Clin Invest 1996; 98: 604-609
72 Verbsky JW, Bach EA, Fang YF, Yang L, Randolph DA, and Fields LE. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells. J Biol Chem 1996; 271: 13976-13980
73 Schnyder B, Lugli S, Feng N, Etter H, Lutz RA, Ryffel B, Sugamura K, Wunderli-Allenspach H, and Moser R. IL-4 and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain (gamma-c). Blood 1996; 87: 4286-4295
74 Soldi R, Primo L, Brizzi MF, Sanavio F, Polentarutti N, Aglietta M, Mantovani A, Pegoraro L, and Bussolino F. Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony stimulating factor. Blood. 1997. in press
75 Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, and Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996; 97: 1715-1722
76 Miyaloto S, Maki M, Schmitt MJ, Hatanaka M, and Verna M. Tumor necrosis factor alpha-induced phosphorylation of IkBalpha is signal for its degradation but not dissociation from NF-kB. Proc Natl Acad Sci USA 1994; 91: 12740-12744
77 Read MA, Whidey MZ, Williams AJ, and Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503-512
78 Bennett BL, Lacson RG, Chen CC, Cruz R, Wheeler JS, Kletzien RJ, Tomasselli AG, Heinrikson RL, and Manning AM. Identification of signal-induced IkB-a kinases in human endothelial cells. J Biol Chem 1996; 271: 19680-19688
79 Chen CC, Rosenbloom CL, Anderson DC, and Manning AM. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J Immunol 1995; 155: 3538-3545
80 Johnson DR, Douglas I, Jahnke A, Ghosh S, and Pober JS. A sustained reduction in IKappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells. J Biol Chem 1996; 271: 16317-16322
81 Wrighton C, Hofer Warbinek RJ, Moll T, Eytner R, Bach FH, and de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IkappaBalpha, an inhibitor of the transcription factor NF-kappaB. J Exp Med 1996; 183: 1013-1022
82 Faruqi R, deal Motte C, and DiCorleto PE. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994; 94: 592-600
83 Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, and Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866-1874
84 Orthner CL, Rodgers GM, and Fitzgerald LA. Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists. Blood 1995; 86: 436-443
85 Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, and Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocytes adhesion molecule expression. Immunity 1995; 2: 493-506
86 de Martin.R, Vanhove B, Cheng Q, Hofer E, Csizmadia V, Winkler H, and Bach FH. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J 1993; 12: 2773-2779
87 Groves RW, Giri J, Sims J, Dower SK, and Kupper TS. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implication for IL-1-mediated processes in epidermis. J Immunol 1995; 154: 4065-4072
88 d’Aniello EM, Breviario F, Martin Padura I, Lampugnani MG, Dejana E, Mantovani A, and Introna M. Interleukin-1 and tumor necrosis factor induce transient expression of an inhibitor of nuclear factor kB in endothelial cells. Endothelium 1993; 1: 161-165
89 Lindner V, and Collins T. Expression of NF-kB and IkB-alpha by aortic endothelium in an arterial injury model. Am J Pathol 1996; 148: 427-438
90 Dixit VM, Green S, Sarma V, Holzman LB, Wolf FW, O’Rourke K, Ward PA, Prochownik EV, and Marks RM. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 1990; 265: 2973-2978
91 Opipari A.W.J, Hu HM, Yabkowitz R, and Dixit VM. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992; 267: 12424-12427
92 Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, and Ferran C. A20 bloks endothelial cell activation through a NF-kappaB-dependent machanism. J Biol Chem 1996; 271: 18068-18073
93 Miyagishi R, Kikuchi S, Fukazawa T, and Tashiro K. Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J Neurol Sci 1995; 129: 223-227
94 Ahmad M, Marui N, Alexander RW, and Medford RM. Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif. J Biol Chem 1995; 270: 8976-8983
95 Schindler U, and Baichwal VR. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol 1994; 14: 5820-5831
96 Hooft van Huijsduijnen R, Pescini R, and DeLamarter JF. Two distinct NF-kappa B complexes differing in their larger subunit bind the E-selectin promoter kappa B element. Nucleic Acids Res 1993; 21: 3711-3717
97 Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, and Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995; 09: 899-909
98 Pescini R, Kaszubska W, Whelan J, DeLamarter JF, and Hooft van Huijsduijnen R. ATF-aO, a novel variant of the ATF/ CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers. J Biol Chem 1994; 269: 1159-1165
99 Lewis H, Kaszubska W, DeLamarter JF, and Whelan J. Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine- induced expression of the E-selectin promoter. Mol Cell Biol 1994; 14: 5701-5709
100 Neish AS, Williams AJ, Palmer HJ, Whitley MZ, and Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 1992; 176: 1583-1593
101 Iademarco MF, McQuillan JJ, Rosen GD, and Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992; 267: 16323-16329
102 Shu HB, Agranoff AB, Nabel EG, Leung K, Duckett CS, Neish AS, Collins T, and Nabel GJ. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. Mol Cell Biol 1993; 13: 6283-6289
103 Neish AS, Khachigian LM, Park A, Baichwal VR, and Collins T. Spl is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1. J Biol Chem 1995; 270: 28903-28909
104 Neish AS, Read MA, Thanos D, Pine R, Maniatis T, and Collins T. Endothelial interferon regulatory factor 1 cooperates with NF-kB as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 1995; 15: 2558-2569
105 Gille J, SwerlickR A, Lawley TJ, and Caughman SW. Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood 1996; 87: 211-217
106 Ledebur HC, and Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells - Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem 1995; 270: 933-943
107 Parry GC, and Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 1994; 269: 20823-20825
108 Hou J, Baichwal V, and Cao Z. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1994; 91: 11641-11645
109 Look D, Pelletier MR, and Holtzman MJ. Selective interaction of a subset of interferon-gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM- 1) gene promoter controls the pattern of expression on epithelial cells. J Biol Chem 1994; 269: 8952-8958
110 Roebuck KA, Rahman A, Lakshminarayanan V, Janakidevi K. and Malik AB. H202 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem 1995; 270: 18966-18974
111 Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Muller M, Bohrer H, Greten J, and et a. Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J Biol Chem 1995; 270: 26419-26432
112 Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9: 883-889
113 Moll T, Czyz M, Holzmuller H, Hofer Warbinek R, Wagner E, Winkler H, Bach FH, and Hofer E. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Spl-like transcription factors. J Biol Chem 1995; 270: 3849-3857
114 Janknecht R, and Hunter TA. growing coactivator network. Nature 1996; 383: 22-23
115 Gearing AJ, and Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512
116 Lassalle P, Molet S, Janin A, Van der Heyden J, Tavernier J, Fiers W, Devos R, and Tonnel AB. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 1996; 271: 20458-20464